US20020013522A1 - Medical apparatus for use by a patient for medical self treatment of diabetes - Google Patents

Medical apparatus for use by a patient for medical self treatment of diabetes Download PDF

Info

Publication number
US20020013522A1
US20020013522A1 US09/870,392 US87039201A US2002013522A1 US 20020013522 A1 US20020013522 A1 US 20020013522A1 US 87039201 A US87039201 A US 87039201A US 2002013522 A1 US2002013522 A1 US 2002013522A1
Authority
US
United States
Prior art keywords
insulin
devices
doser
medical
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/870,392
Inventor
Steffen Lav
Jens Munk
Brian Ritsing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8096703&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20020013522(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to US09/870,392 priority Critical patent/US20020013522A1/en
Publication of US20020013522A1 publication Critical patent/US20020013522A1/en
Priority to US11/787,561 priority patent/US20070244412A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/19Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150267Modular design or construction, i.e. subunits are assembled separately before being joined together or the device comprises interchangeable or detachable modules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150358Strips for collecting blood, e.g. absorbent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150412Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15107Piercing being assisted by a triggering mechanism
    • A61B5/15113Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15186Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/157Devices characterised by integrated means for measuring characteristics of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/24Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0295Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3368Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3129Syringe barrels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31525Dosing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533Dosing mechanisms, i.e. setting a dose
    • A61M5/31545Setting modes for dosing
    • A61M5/31546Electrically operated dose setting, e.g. input via touch screen or plus/minus buttons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533Dosing mechanisms, i.e. setting a dose
    • A61M5/31545Setting modes for dosing
    • A61M5/31548Mechanically operated dose setting member
    • A61M5/3155Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
    • A61M5/31553Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe without axial movement of dose setting member

Definitions

  • This invention comprises a medical apparatus for use by a patient for medical self treatment of diabetes, the treatment including a first operation and at least a second operation, the apparatus comprising a first device for performing the first operation and a second device for performing the second operation.
  • the individual devices may be arranged for various respective functions relevant to the treatment of diabetes, such as: a lancet device, a body fluid analyser, a dosing apparatus for administering a predetermined dose of medication to the patient. Further, there is a number of other aids which the diabetic patient uses, e.g. test strips for the blood analyser, napkins for wiping off blood, extra insulin carpoule, glucose tablets, waste containers, etc.
  • the object of the invention is to make the individual devices physically interconnectible with a view to optimizing self-treatment of diabetes.
  • Another object is to construct the individual interconnectible devices such that the optimum treatment is as independent as possible of the specific situation of the user.
  • a further object of the invention is to provide an apparatus of the present type for self-treatment of diseases, where, on one hand, the user is certain that he has all the devices which will be relevant for a future span of time, and on the other hand, is confident about the use of the apparatus.
  • the object is achieved by making at least a BGM and an insulin doser interconnectible to a single device. Precisely this combination promotes the insulin treatment, as it will be more obvious to the user to adjust the insulin balance if he has just measured his blood sugar; or if the user knows that he is soon to take insulin, it will be more obvious to check the blood sugar content first. This combination departs from the common view where these two devices do not belong together, presumably because the manufacturers have specialized within either the one or the other device.
  • the invention is not restricted to the combination of BGM and insulin doser devices, as these devices may be coupled with other devices which are used in the insulin treatment.
  • a blood sugar measuring device normally comprises a temperature monitoring device, and in a preferred embodiment the latter device is arranged such that it is close to the insulin carpoule when the blood fluid analyser and the insulin injecting device are coupled together according to the invention.
  • the temperature monitoring device may hereby be used not only for adjusting the blood sugar measurement, but may also be used to warn the user if the apparatus has been in a too hot environment and the insulin has been destroyed. This is a particular technical advantage by combining precisely the BGM and the doser.
  • one or more of the devices may have several sizes. This may be relevant particularly for the insulin injecting device and for a storage device, enabling the user to combine precisely the devices of the relevant size which will be needed in a given situation, such as an evening party, a working day,. a weekend or on a holiday.
  • the optimum treatment achieved by the apparatus of the invention is hereby more independent of the specific situations in which the user may be, and in which the treatment would be inconvenient with the known separate devices.
  • the devices have their own easily recognisable functions which are well-known to the user.
  • the invention does not exclude the use of others of the user's older (i.e. well-known and secure) devices in combination with the invention, which, however, inspires the user to extend his self-treatment apparatus with units which fit together according to the invention.
  • FIG. 1 shows a prior art doser with a conventional cap
  • FIG. 2 shows a doser and a cap with a BGM attached
  • FIG. 3 shows a doser and a cap with a BGM and a lancet device attached
  • FIG. 4 shows a doser and a cap with a BGM, a lancet device and a container for test strips attached
  • FIG. 5 shows a cap with a BGM, a lancet device, a test strip container and an additional container together with useful/needed extras
  • FIG. 6 shows a cap with BGM, a lancet device, a test strip container and a mini-doser and a half-size container together with useful/needed extras
  • FIG. 7 shows a first combination of the items presented in FIGS. 1 - 6 .
  • FIG. 8 shows a second combination of the items presented in FIGS. 1 - 6 .
  • FIG. 9 shows a third combination of the items presented in FIGS. 1 - 6 .
  • FIGS. 7 - 11 show some useful combinations which illustrate the use of the invention.
  • the invention also opens up the possibility of a wide variety of combinations as each of said devices may be provided in several sizes.
  • the preferred insulin dosing device may e.g. be replaced by two insulin injection pens of half the size, and a waste container may be inserted instead of one of these pens.
  • FIG. 1 shows a doser 20 and a cap 10 .
  • the doser 20 comprises a turning wheel 21 for adjusting, either electronically or manually, the level/amount of medication to be administered, and a display 22 that shows the currently selected amount of medication to be administered.
  • the doser 20 has processing means and storage facilities, like a CPU and RAM, for storing data, like the time, date and amount of medication of the last couple of administrations. This information can be shown in the display 22 at request.
  • the doser 20 further comprises a carpoule (not shown) that contains the medication, and is fitted with a needle 27 through which the medication is administered.
  • the doser 20 has a transparent window 25 so that the amount of medication left in the carpoule can readily be identified.
  • the cap 10 can be fitted to the doser 20 so that one single compact unit and protection of the doser 20 , needle 27 , etc. is obtained.
  • FIG. 2 shows a doser 20 which corresponds to the doser in FIG. 1. Also shown is a cap part 10 , and a BGM 30 .
  • the invention is based on the circumstance that the doser 20 and the BGM 30 should be used together very frequently, one embodiment of the invention might be a cap where the BGM 30 is an integral part.
  • This has the advantage that when the cap unit 35 is fitted to the doser 20 , one set of parts associated functionally can be obtained in a very compact and convenient form.
  • Another option available to the user by this arrangement is that if in special cases the BGM 30 is not needed in a given situation, the user can simply leave the BGM 30 at home, thereby reducing and keeping the size of the device to an absolute minimum.
  • the BGM 30 has means 34 for inserting test strips 52 (not shown, see FIG. 4) containing a sample of blood, for analysis by the BGM 30 by operating the buttons 36 .
  • the result of the analysis is shown in the display 32 .
  • the cap unit 35 may also be provided with a temperature sensor 12 , which determines the outside temperature during operation of the BGM 30 . This temperature is needed for the calibration of the BGM 30 prior to the analysis of a blood sample.
  • the temperature. sensor 12 could be placed close to the carpoule, so that an additional benefit, apart from being used in the calibration, is achieved when the cap unit 35 is fitted over the doser 20 . In this location the sensor 12 can monitor the temperature of the medication contained inside the carpoule. This additional feature is very convenient if the medication is sensitive to temperature and could be ruined or damaged if the temperature of the medication is outside a given interval.
  • the BGM 30 could notify the user if the medication has been exposed to a harmful temperature, which improves the user's safety, especially in the case of the medication being insulin, where the consumption/injection of damaged medicine could cause life-threatening situations.
  • FIG. 3 shows a doser 20 and a cap unit 35 , preferably comprising the cap 10 and the BGM 30 , like the cap unit in FIG. 2, but with the additional feature of having a lancet device 40 removably attached to the BGM 30 by the locking means 31 .
  • This lancet device 40 is used by first loading the lancet device through the grip 44 and then pressing the button 42 , which releases the lancet, piercing the skin, so that a blood sample can be obtained. With this inclusion the lancet device 40 is always at hand. This has the advantage that a lancet device 40 always is available, for taking a blood sample and applying it to a test strip 52 .
  • test-strip 52 can then be inserted via the means 34 into the BGM 30 , which will start analysing the blood sample and, after completion of the analysis, will show the result in the display 32 . It is very useful to have the BGM 30 and the lancet device 40 attached together in one compact unit, since a BGM 30 would not normally be used without the lancet device 40 , thereby avoiding the fuss and uncertainty of using multiple devices of perhaps different makes.
  • FIG. 4 shows a doser 20 and a cap unit 35 from FIG. 3, but where the additional feature of a test strip container 50 for the safe keeping/storing of test-strips 52 in the space 55 can be added/attached through locking means 31 .
  • a test strip 52 will always be available.
  • This addition further strengthens the use of the compact unit obtained, when the cap unit 35 is fitted to the doser 20 .
  • the user can either have a single compact unit where all the means for taking and analysing a blood sample are available, or have an even smaller compact unit with just the items (e.g. doser 20 with a BGM 30 plus either a test strip container 50 or a lancet) that are needed, depending on the specific situation.
  • FIG. 4 shows one of the many possible combinations which may be achieved with the apparatus according to the invention.
  • Other examples of expedient combinations are shown in FIGS. 7 - 9 .
  • the combination shown in FIG. 4 has the general advantage that it may induce the user to make some additional blood sugar measurements and possibly regulate with insulin injection when the parts are in an assembled state as one unit.
  • FIG. 5 shows a cap unit 35 that corresponds to the cap unit in FIG. 4.
  • a container unit 60 with a relative large space 69 for storing the items needed everyday for self-treatment.
  • a diabetic e.g. such items could be a napkin 61 for wiping excessive blood after a sample has been taken, a waste container 62 for receiving used items, an extra carpoule 63 which could contain another type of insulin, spare needles 27 for the doser, spare lancets 65 for the lancet device 40 , some glucose in the form of glucose tablets 64 , etc.
  • the injection of insulin may be replaced by administration of pills which may be stored in the container, which thus replaces the doser described previously. All these items, or the most relevant ones for a given situation, could be held in the container space 69 for easy retrieval, when needed.
  • the user had to carry a bag for each device (BGM, doser, lancet device, etc.) with the respective accessories. So when the cap unit 35 is fitted to the container unit 60 , a single compact, easily portable unit is obtained, which can be customised to meet an individual need for an individual day or situation.
  • the individual devices may also be interconnected without the BMG and the doser being coupled together according to the invention.
  • the doser 20 is not needed—a diabetic does not always need a doser in all situations, since sometimes he only need to observe the glucose level in his blood and regulate this level through a diet—one compact unit with all necessary items readily available is obtained.
  • the doser 20 may be fitted with an ordinary cap 10 , and thus there will just be two units that contain everything needed in every situation in a very compact and convenient form.
  • FIG. 6 shows a cap unit 35 and extras 61 - 65 and 27 corresponding to the unit and extras in FIG. 5. Also shown is a simple small-sized (e.g. disposable) doser 80 (e.g. an insulin injecting pen) with a turning wheel 85 for adjusting the level/amount of medication to be administered. During the adjustment, a display 84 shows the currently selected amount of medication to be administered. After the appropriate level of medication has been set, the user can press the release button 82 , which manually injects/administers the selected amount of medication through the needle 87 .
  • the doser 80 further comprises a carpoule (not shown) that contains the medication.
  • the doser 80 has a transparent window 88 , so that the amount of medication left in the carpoule readily can be identified.
  • This embodiment also includes a container unit 70 , which is half the size of the container unit 60 in FIG. 5. These small size units 70 , 80 can be fitted into the cap unit 35 so thereby forming one compact self-treatment unit.
  • an optimal compact set can be customised with the things needed for a given situation.
  • the set can either be configured to meet a situation where all the items are needed, thus ending up with two compact units, namely the doser 20 with an ordinary cap 10 and a cap unit 35 with the large container 60 that contains some or all of the extras 61 - 65 and 27 , or be configured to a minimal set containing just items needed for one single situation, e.g. the small doser 80 , the half-size container 70 fitted into the cap unit 35 with/without the BGM 30 , the lancet device 40 and the test strip container 50 , depending on the specific situation.
  • FIG. 7 shows a combination of the cap 10 , the BMG 30 and the storage container 60 .
  • a combination of devices is relevant e.g. in connection with type 2 diabetics who may take insulin regulating medication in tablet form.
  • the storage container 60 may contain spare lancets 65 (which may belong to another make of lancet devices, which are not shown in the combination in FIG. 7), test strips 52 , glucose in the form of glucose tablets 64 and the insulin regulating medication in tablet form.
  • Another use of the combination shown in FIG. 7 is non-refrigerated storage of extra insulin, the temperature then being monitored by the temperature monitoring device 12 .
  • the combination shown in FIG. 8 might be called all in one.
  • the insulin injecting device is replaced by an insulin injecting pen of half the size, which gives room for a container 70 (half as large as the container 60 in FIG. 7).
  • FIG. 9 shows another possible combination, using two insulin injecting pens so that the user may carry rapid action insulin as well as slow action insulin.
  • One of the pens may also contain one of the very rapid action insulin analogs mentioned above.
  • the combination in FIG. 9 may also be supplemented with a lancet device as shown in FIG. 8.
  • an apparatus according to the invention may also comprise devices which may be interconnected and varied in the longitudinal direction.

Abstract

The invention relates to an apparatus for self-treatment of diabetes. The apparatus is particularly advantageous by comprising a plurality of devices each of which has its own dedicated function corresponding to a number of acts which a diabetic must perform on himself. The individual devices are mutually interconnectible, and the combination comprises at least a body fluid analyser and a dosing apparatus for administering a predetermined dose of insulin to the patient. Each of the devices may be provided in several sizes so that the user himself may combine the relevant devices of the relevant size with respect to the current need. This reduces the risk of forgetting parts of the equipment, and the confidence of using the equipment is enhanced because it is evident to the user that it is a complete apparatus consisting of unified parts.

Description

  • This invention comprises a medical apparatus for use by a patient for medical self treatment of diabetes, the treatment including a first operation and at least a second operation, the apparatus comprising a first device for performing the first operation and a second device for performing the second operation. [0001]
  • For a number of years it has been possible to purchase various devices for the treatment of diabetes, e.g. for injecting insulin, for measuring blood sugar (such a device is referred to as BGM below), for withdrawing blood samples, and other accessories, the purpose of which is to enable the patient to nurse his disease discretely and with a high standard of hygiene. Many diabetic patients are elderly people who can easily get insecure with respect to the medical equipment, but also many young people need to assure themselves that the equipment is in order, i.e. that everything is there. Or as one must often say to one's children: You have got it all, haven't you?[0002]
  • It has also been attempted to build several of the necessary devices together to a single integral unit, see e.g. U.S. Pat. No. 5,536,249. This is not the ideal solution either, because such multi-functional devices are normally difficult to operate. A patient holding a gadget in his hand may not be entirely secure and convinced that he has set the apparatus to precisely the function to be performed by means of programmable computers. The more complicated an apparatus, the greater the risk of malfunction, meaning that two such multi-functional devices should actually be at disposal. [0003]
  • The individual devices may be arranged for various respective functions relevant to the treatment of diabetes, such as: a lancet device, a body fluid analyser, a dosing apparatus for administering a predetermined dose of medication to the patient. Further, there is a number of other aids which the diabetic patient uses, e.g. test strips for the blood analyser, napkins for wiping off blood, extra insulin carpoule, glucose tablets, waste containers, etc. [0004]
  • It is not common to build two individual devices together, as manufacturers within the field have tended to specialize in a single device. However, U.S. Pat. No. 4,469,110 discloses a lancet device and a simple form of BGM (the calorimetric measuring principle) which may be mutually interconnected to a single portable unit. [0005]
  • The object of the invention is to make the individual devices physically interconnectible with a view to optimizing self-treatment of diabetes. [0006]
  • Another object is to construct the individual interconnectible devices such that the optimum treatment is as independent as possible of the specific situation of the user. [0007]
  • A further object of the invention is to provide an apparatus of the present type for self-treatment of diseases, where, on one hand, the user is certain that he has all the devices which will be relevant for a future span of time, and on the other hand, is confident about the use of the apparatus. [0008]
  • The object is achieved by making at least a BGM and an insulin doser interconnectible to a single device. Precisely this combination promotes the insulin treatment, as it will be more obvious to the user to adjust the insulin balance if he has just measured his blood sugar; or if the user knows that he is soon to take insulin, it will be more obvious to check the blood sugar content first. This combination departs from the common view where these two devices do not belong together, presumably because the manufacturers have specialized within either the one or the other device. [0009]
  • The invention is not restricted to the combination of BGM and insulin doser devices, as these devices may be coupled with other devices which are used in the insulin treatment. [0010]
  • The fact that the individual devices may be combined so that the apparatus covers precisely a given need, means that the apparatus takes up as little space is possible, it being simultaneously easy, even for visually handicapped users, to identify each individual device, so that they will be quite confident that the units fit together. When the devices fit together physically, the users will also be confident that the e.g. the measuring units used are the same. This improves the confidence of using the apparatus of the invention. [0011]
  • A blood sugar measuring device normally comprises a temperature monitoring device, and in a preferred embodiment the latter device is arranged such that it is close to the insulin carpoule when the blood fluid analyser and the insulin injecting device are coupled together according to the invention. The temperature monitoring device may hereby be used not only for adjusting the blood sugar measurement, but may also be used to warn the user if the apparatus has been in a too hot environment and the insulin has been destroyed. This is a particular technical advantage by combining precisely the BGM and the doser. [0012]
  • In addition to the possibility of coupling various devices together as needed, it is also possible for one or more of the devices to have several sizes. This may be relevant particularly for the insulin injecting device and for a storage device, enabling the user to combine precisely the devices of the relevant size which will be needed in a given situation, such as an evening party, a working day,. a weekend or on a holiday. The optimum treatment achieved by the apparatus of the invention is hereby more independent of the specific situations in which the user may be, and in which the treatment would be inconvenient with the known separate devices. [0013]
  • In the invention, the devices have their own easily recognisable functions which are well-known to the user. The invention does not exclude the use of others of the user's older (i.e. well-known and secure) devices in combination with the invention, which, however, inspires the user to extend his self-treatment apparatus with units which fit together according to the invention. [0014]
  • Conclusively, it is an essential feature of the invention that the stated advantages are of great importance to the user's perception of and habituation to regarding BGM measurement and insulin dosing as closely unified actions, which results in a better self-treatment.[0015]
  • FIG. 1 shows a prior art doser with a conventional cap, [0016]
  • FIG. 2 shows a doser and a cap with a BGM attached, [0017]
  • FIG. 3 shows a doser and a cap with a BGM and a lancet device attached, [0018]
  • FIG. 4 shows a doser and a cap with a BGM, a lancet device and a container for test strips attached, [0019]
  • FIG. 5 shows a cap with a BGM, a lancet device, a test strip container and an additional container together with useful/needed extras, [0020]
  • FIG. 6 shows a cap with BGM, a lancet device, a test strip container and a mini-doser and a half-size container together with useful/needed extras, [0021]
  • FIG. 7 shows a first combination of the items presented in FIGS. [0022] 1-6,
  • FIG. 8 shows a second combination of the items presented in FIGS. [0023] 1-6,
  • FIG. 9 shows a third combination of the items presented in FIGS. [0024] 1-6,
  • In the following an embodiment of the invention will be described in detail with reference to FIGS. [0025] 1-6. FIGS. 7-11 show some useful combinations which illustrate the use of the invention.
  • The invention also opens up the possibility of a wide variety of combinations as each of said devices may be provided in several sizes. The preferred insulin dosing device may e.g. be replaced by two insulin injection pens of half the size, and a waste container may be inserted instead of one of these pens. [0026]
  • FIG. 1 shows a [0027] doser 20 and a cap 10. The doser 20 comprises a turning wheel 21 for adjusting, either electronically or manually, the level/amount of medication to be administered, and a display 22 that shows the currently selected amount of medication to be administered. The doser 20 has processing means and storage facilities, like a CPU and RAM, for storing data, like the time, date and amount of medication of the last couple of administrations. This information can be shown in the display 22 at request. The doser 20 further comprises a carpoule (not shown) that contains the medication, and is fitted with a needle 27 through which the medication is administered. The doser 20 has a transparent window 25 so that the amount of medication left in the carpoule can readily be identified. The cap 10 can be fitted to the doser 20 so that one single compact unit and protection of the doser 20, needle 27, etc. is obtained.
  • FIG. 2 shows a [0028] doser 20 which corresponds to the doser in FIG. 1. Also shown is a cap part 10, and a BGM 30. The invention is based on the circumstance that the doser 20 and the BGM 30 should be used together very frequently, one embodiment of the invention might be a cap where the BGM 30 is an integral part. Another embodiment, which is the one shown in FIG. 2 and described later, could be one where the BGM 30 can be fitted removable by the locking means 31 to the cap part 10 in such a way that a single unit 35 serving as a cap is formed. This has the advantage that when the cap unit 35 is fitted to the doser 20, one set of parts associated functionally can be obtained in a very compact and convenient form. Another option available to the user by this arrangement is that if in special cases the BGM 30 is not needed in a given situation, the user can simply leave the BGM 30 at home, thereby reducing and keeping the size of the device to an absolute minimum.
  • The [0029] BGM 30 has means 34 for inserting test strips 52 (not shown, see FIG. 4) containing a sample of blood, for analysis by the BGM 30 by operating the buttons 36. The result of the analysis is shown in the display 32.
  • The [0030] cap unit 35 may also be provided with a temperature sensor 12, which determines the outside temperature during operation of the BGM 30. This temperature is needed for the calibration of the BGM 30 prior to the analysis of a blood sample. The temperature. sensor 12 could be placed close to the carpoule, so that an additional benefit, apart from being used in the calibration, is achieved when the cap unit 35 is fitted over the doser 20. In this location the sensor 12 can monitor the temperature of the medication contained inside the carpoule. This additional feature is very convenient if the medication is sensitive to temperature and could be ruined or damaged if the temperature of the medication is outside a given interval. Thus the BGM 30 could notify the user if the medication has been exposed to a harmful temperature, which improves the user's safety, especially in the case of the medication being insulin, where the consumption/injection of damaged medicine could cause life-threatening situations.
  • FIG. 3 shows a [0031] doser 20 and a cap unit 35, preferably comprising the cap 10 and the BGM 30, like the cap unit in FIG. 2, but with the additional feature of having a lancet device 40 removably attached to the BGM 30 by the locking means 31. This lancet device 40 is used by first loading the lancet device through the grip 44 and then pressing the button 42, which releases the lancet, piercing the skin, so that a blood sample can be obtained. With this inclusion the lancet device 40 is always at hand. This has the advantage that a lancet device 40 always is available, for taking a blood sample and applying it to a test strip 52. The test-strip 52 can then be inserted via the means 34 into the BGM 30, which will start analysing the blood sample and, after completion of the analysis, will show the result in the display 32. It is very useful to have the BGM 30 and the lancet device 40 attached together in one compact unit, since a BGM 30 would not normally be used without the lancet device 40, thereby avoiding the fuss and uncertainty of using multiple devices of perhaps different makes. On the other hand, if the user already has a lancet device and is accustomed to and familiar with the use of this particular lancet device, he can still use this original lancet device and just use the remaining items, which will be a compact set consisting of a doser 20 and a BGM 30; The cost will be reduced hereby.
  • FIG. 4 shows a [0032] doser 20 and a cap unit 35 from FIG. 3, but where the additional feature of a test strip container 50 for the safe keeping/storing of test-strips 52 in the space 55 can be added/attached through locking means 31. With this addition a test strip 52 will always be available. This addition further strengthens the use of the compact unit obtained, when the cap unit 35 is fitted to the doser 20. Now the user can either have a single compact unit where all the means for taking and analysing a blood sample are available, or have an even smaller compact unit with just the items (e.g. doser 20 with a BGM 30 plus either a test strip container 50 or a lancet) that are needed, depending on the specific situation.
  • FIG. 4 shows one of the many possible combinations which may be achieved with the apparatus according to the invention. Other examples of expedient combinations are shown in FIGS. [0033] 7-9. The combination shown in FIG. 4 has the general advantage that it may induce the user to make some additional blood sugar measurements and possibly regulate with insulin injection when the parts are in an assembled state as one unit. There are also situations in which many blood sugar measurements and injections are required, viz. in connection with so-called insulin analogs which are very rapid action substances, within the order of 10 minutes.
  • FIG. 5 shows a [0034] cap unit 35 that corresponds to the cap unit in FIG. 4. Instead of having a doser 20, there is now provided a container unit 60 with a relative large space 69 for storing the items needed everyday for self-treatment. For a diabetic, e.g. such items could be a napkin 61 for wiping excessive blood after a sample has been taken, a waste container 62 for receiving used items, an extra carpoule 63 which could contain another type of insulin, spare needles 27 for the doser, spare lancets 65 for the lancet device 40, some glucose in the form of glucose tablets 64, etc. In some situations and in certain forms of diabetes, the injection of insulin may be replaced by administration of pills which may be stored in the container, which thus replaces the doser described previously. All these items, or the most relevant ones for a given situation, could be held in the container space 69 for easy retrieval, when needed. Previously the user had to carry a bag for each device (BGM, doser, lancet device, etc.) with the respective accessories. So when the cap unit 35 is fitted to the container unit 60, a single compact, easily portable unit is obtained, which can be customised to meet an individual need for an individual day or situation.
  • Of course, the individual devices may also be interconnected without the BMG and the doser being coupled together according to the invention. If the [0035] doser 20 is not needed—a diabetic does not always need a doser in all situations, since sometimes he only need to observe the glucose level in his blood and regulate this level through a diet—one compact unit with all necessary items readily available is obtained. If a doser 20 is needed, the doser 20 may be fitted with an ordinary cap 10, and thus there will just be two units that contain everything needed in every situation in a very compact and convenient form.
  • FIG. 6 shows a [0036] cap unit 35 and extras 61-65 and 27 corresponding to the unit and extras in FIG. 5. Also shown is a simple small-sized (e.g. disposable) doser 80 (e.g. an insulin injecting pen) with a turning wheel 85 for adjusting the level/amount of medication to be administered. During the adjustment, a display 84 shows the currently selected amount of medication to be administered. After the appropriate level of medication has been set, the user can press the release button 82, which manually injects/administers the selected amount of medication through the needle 87. The doser 80 further comprises a carpoule (not shown) that contains the medication. The doser 80 has a transparent window 88, so that the amount of medication left in the carpoule readily can be identified. This embodiment also includes a container unit 70, which is half the size of the container unit 60 in FIG. 5. These small size units 70, 80 can be fitted into the cap unit 35 so thereby forming one compact self-treatment unit.
  • So with this set of modules an optimal compact set can be customised with the things needed for a given situation. The set can either be configured to meet a situation where all the items are needed, thus ending up with two compact units, namely the [0037] doser 20 with an ordinary cap 10 and a cap unit 35 with the large container 60 that contains some or all of the extras 61-65 and 27, or be configured to a minimal set containing just items needed for one single situation, e.g. the small doser 80, the half-size container 70 fitted into the cap unit 35 with/without the BGM 30, the lancet device 40 and the test strip container 50, depending on the specific situation.
  • FIG. 7 shows a combination of the [0038] cap 10, the BMG 30 and the storage container 60. Such a combination of devices is relevant e.g. in connection with type 2 diabetics who may take insulin regulating medication in tablet form. Here, the storage container 60 may contain spare lancets 65 (which may belong to another make of lancet devices, which are not shown in the combination in FIG. 7), test strips 52, glucose in the form of glucose tablets 64 and the insulin regulating medication in tablet form. Another use of the combination shown in FIG. 7 is non-refrigerated storage of extra insulin, the temperature then being monitored by the temperature monitoring device 12.
  • The combination shown in FIG. 8 might be called all in one. The insulin injecting device is replaced by an insulin injecting pen of half the size, which gives room for a container [0039] 70 (half as large as the container 60 in FIG. 7).
  • FIG. 9 shows another possible combination, using two insulin injecting pens so that the user may carry rapid action insulin as well as slow action insulin. One of the pens may also contain one of the very rapid action insulin analogs mentioned above. Clearly, the combination in FIG. 9 may also be supplemented with a lancet device as shown in FIG. 8. [0040]
  • It will now be appreciated that there are many possible combinations which allow the user to combine precisely the equipment he needs in a given situation. In the preferred embodiments, the individual devices are combined side by side, and the storage container and the insulin injecting device are shown in the lateral direction in larger or smaller embodiments. Clearly, an apparatus according to the invention may also comprise devices which may be interconnected and varied in the longitudinal direction. [0041]

Claims (10)

1. A medical apparatus for use by a patient for medical self treatment of diabetes, the treatment including a first operation and at least a second operation, the apparatus comprising a first apparatus for performing the first operation and a second apparatus for performing the second operation, characterized in that the first apparatus and the second apparatus can be detachably put together so as to form a single unit portable by the patient, and that said apparatuses at least comprise a body fluid analyser and a dosing apparatus for administering a predetermined dose of insulin to the patient.
2. A medical apparatus according to claim 1, characterized in that the body fluid analyser is a blood glucose monitor.
3. A medical apparatus according to claim 1, characterized in that the dosing apparatus is an insulin injecting device.
4. A medical apparatus according to claim 1, characterized in that the apparatus has storage space for storing a supply of lancets for the body fluid analyser.
5. A medical apparatus according to claim 1, characterized in that the apparatus has storage space for storing a supply of test strips for the body fluid analyser.
6. A medical apparatus according to claim 3, characterized in that the apparatus has storage space for storing an extra supply (carpoule) of insulin.
7. A medical apparatus according to claim 2 and where the blood glucose monitor includes a temperature monitoring device, characterized in that, when the blood glucose monitor and the insulin injecting device are put together, the temperature monitoring device will monitor the temperature of the insulin in the insulin injecting device.
8. An apparatus according to any of the preceding claims, characterized in that any of the said devices may occur in different sizes for interconnection with other devices.
9. An apparatus according to claim 8, characterized in that the insulin injecting device comprises two insulin injecting pens arranged to be received as a pair in said cap.
10. An apparatus according to claim 8, characterized in that it comprises an insulin injecting pen and a storage device to be received as a pair in said cap.
US09/870,392 1998-05-20 2001-05-30 Medical apparatus for use by a patient for medical self treatment of diabetes Abandoned US20020013522A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/870,392 US20020013522A1 (en) 1998-05-20 2001-05-30 Medical apparatus for use by a patient for medical self treatment of diabetes
US11/787,561 US20070244412A1 (en) 1998-05-20 2007-04-16 Medical apparatus for use by a patient for medical self treatment of diabetes

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA199800714 1998-05-20
DK71498 1998-05-20
US8718798P 1998-05-29 1998-05-29
US09/312,796 US6302855B1 (en) 1998-05-20 1999-05-17 Medical apparatus for use by a patient for medical self treatment of diabetes
US09/870,392 US20020013522A1 (en) 1998-05-20 2001-05-30 Medical apparatus for use by a patient for medical self treatment of diabetes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/312,796 Continuation US6302855B1 (en) 1998-05-20 1999-05-17 Medical apparatus for use by a patient for medical self treatment of diabetes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/787,561 Continuation US20070244412A1 (en) 1998-05-20 2007-04-16 Medical apparatus for use by a patient for medical self treatment of diabetes

Publications (1)

Publication Number Publication Date
US20020013522A1 true US20020013522A1 (en) 2002-01-31

Family

ID=8096703

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/312,796 Expired - Lifetime US6302855B1 (en) 1998-05-20 1999-05-17 Medical apparatus for use by a patient for medical self treatment of diabetes
US09/870,392 Abandoned US20020013522A1 (en) 1998-05-20 2001-05-30 Medical apparatus for use by a patient for medical self treatment of diabetes
US11/787,561 Abandoned US20070244412A1 (en) 1998-05-20 2007-04-16 Medical apparatus for use by a patient for medical self treatment of diabetes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/312,796 Expired - Lifetime US6302855B1 (en) 1998-05-20 1999-05-17 Medical apparatus for use by a patient for medical self treatment of diabetes

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/787,561 Abandoned US20070244412A1 (en) 1998-05-20 2007-04-16 Medical apparatus for use by a patient for medical self treatment of diabetes

Country Status (22)

Country Link
US (3) US6302855B1 (en)
EP (1) EP1079876B1 (en)
JP (1) JP2002515302A (en)
KR (1) KR20010025042A (en)
CN (1) CN1301184A (en)
AT (1) ATE250945T1 (en)
AU (1) AU748281B2 (en)
BR (1) BR9911051A (en)
CA (1) CA2332368C (en)
CZ (1) CZ20004261A3 (en)
DE (1) DE69911767T2 (en)
DK (1) DK1079876T3 (en)
ES (1) ES2207942T3 (en)
HU (1) HUP0102074A3 (en)
IL (1) IL139242A0 (en)
NO (1) NO20005815L (en)
PL (1) PL344305A1 (en)
PT (1) PT1079876E (en)
RU (1) RU2221594C2 (en)
TW (1) TW477685B (en)
WO (1) WO1999059657A1 (en)
ZA (1) ZA200006159B (en)

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020074345A1 (en) * 2000-10-17 2002-06-20 Schneider Patricia G. Emergency medical dispensing card
US20040054318A1 (en) * 2000-12-22 2004-03-18 Langley Christopher Nigel Pen-type injector having an electronic control unit
US20050126938A1 (en) * 2002-02-15 2005-06-16 Yoshiharu Uehata Integrally storable adaptor
US20050182306A1 (en) * 2004-02-17 2005-08-18 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US20060034728A1 (en) * 2004-08-11 2006-02-16 Kloepfer Hans G Methods and apparatus for analyzing an analysis fluid
US20060047284A1 (en) * 2004-08-25 2006-03-02 Gresham Richard D Gel seal for a surgical trocar apparatus
US20070239116A1 (en) * 2004-04-30 2007-10-11 Mark Follman Systems and methods for administering a medical regimen
US20080278332A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281179A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281171A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281840A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080278333A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080319296A1 (en) * 2007-06-21 2008-12-25 Abbott Diabetes Care, Inc. Health monitor
US20090043265A1 (en) * 2007-08-10 2009-02-12 Schneider Robert M Method and apparatus for auto injection of a therapeutic
US20090054747A1 (en) * 2005-10-31 2009-02-26 Abbott Diabetes Care, Inc. Method and system for providing analyte sensor tester isolation
US20090076465A1 (en) * 2007-09-17 2009-03-19 Tyco Healthcare Group Lp Composite seal and method for manufacturing
US20090105571A1 (en) * 2006-06-30 2009-04-23 Abbott Diabetes Care, Inc. Method and System for Providing Data Communication in Data Management Systems
US20090284372A1 (en) * 2003-06-10 2009-11-19 Abbott Diabetes Care Inc. Glucose Measuring Device For Use In Personal Area Network
US20100045231A1 (en) * 2006-03-31 2010-02-25 Abbott Diabetes Care Inc. Method and System for Powering an Electronic Device
US20100076284A1 (en) * 2007-06-21 2010-03-25 Abbott Diabetes Care Inc. Health Management Devices and Methods
US20100076288A1 (en) * 2003-04-04 2010-03-25 Brian Edmond Connolly Method and System for Transferring Analyte Test Data
US20100198034A1 (en) * 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
US20100274220A1 (en) * 2005-11-04 2010-10-28 Abbott Diabetes Care Inc. Method and System for Providing Basal Profile Modification in Analyte Monitoring and Management Systems
US20110044333A1 (en) * 2008-05-30 2011-02-24 Abbott Diabetes Care Inc. Close Proximity Communication Device and Methods
US20110054282A1 (en) * 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte Monitoring System and Methods for Managing Power and Noise
US20110060530A1 (en) * 2009-08-31 2011-03-10 Abbott Diabetes Care Inc. Analyte Signal Processing Device and Methods
US20110213225A1 (en) * 2009-08-31 2011-09-01 Abbott Diabetes Care Inc. Medical devices and methods
US20120046606A1 (en) * 2010-08-18 2012-02-23 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9088452B2 (en) 2009-04-29 2015-07-21 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2016022704A1 (en) * 2014-08-05 2016-02-11 Bihn Hunter S Diabetic medication delivery pen packet
US9357961B2 (en) 2013-02-22 2016-06-07 Thuban, Inc. Device for enabling patient self testing and treatment self- administration and system using the device for managing the patient's health care
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9861768B2 (en) 2014-01-28 2018-01-09 Panasonic Healthcare Holdings Co., Ltd. Pharmaceutical injection device, and pharmaceutical management system
US20180058521A1 (en) * 2016-08-31 2018-03-01 Otis Elevator Company Auxiliary brake device, brake disc assembly, base disc assembly and passenger conveyor
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US10022499B2 (en) 2007-02-15 2018-07-17 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US10318915B2 (en) 2012-09-26 2019-06-11 Thuban, Inc. Healthcare system for recording and monitoring transactions of system participants
US10857304B2 (en) 2016-03-25 2020-12-08 Eli Lilly And Company Determination of a dose set and delivered in a medication delivery device
US20210113777A1 (en) * 2019-10-18 2021-04-22 Amarillo Biosciences, Inc Smart drug injection device
US11266788B2 (en) 2016-04-19 2022-03-08 Eli Lilly And Company Determination of a dose in a medication delivery device using two moving arrays with teeth and a sensor
US11452819B2 (en) 2016-12-15 2022-09-27 Eli Lilly And Company Medication delivery device with sensing system
US11471607B2 (en) 2016-08-12 2022-10-18 Eli Lilly And Company Dose sensing mechanism in a medication delivery device
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations

Families Citing this family (283)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6540672B1 (en) * 1998-12-09 2003-04-01 Novo Nordisk A/S Medical system and a method of controlling the system for use by a patient for medical self treatment
US6192891B1 (en) * 1999-04-26 2001-02-27 Becton Dickinson And Company Integrated system including medication delivery pen, blood monitoring device, and lancer
DE19952215C2 (en) * 1999-10-29 2001-10-31 Roche Diagnostics Gmbh Test element analysis system
TW499314B (en) * 2000-05-30 2002-08-21 Novo Nordisk As A medication delivery device with replaceable cooperating modules and a method of making same
ATE384543T1 (en) * 2000-05-30 2008-02-15 Novo Nordisk As MEDICATION DISPENSING DEVICE HAVING INTERCHANGEABLE, COOPERATIVE MODULES
JP2004503337A (en) 2000-07-14 2004-02-05 ノボ ノルディスク アクティーゼルスカブ Liquid drug ejection device and method for ejecting a desired dose
EP1203563A3 (en) * 2000-10-31 2004-01-02 Boehringer Mannheim Gmbh Analyzing mean with integrated lancet
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7063234B2 (en) * 2000-12-29 2006-06-20 Csp Technologies, Inc. Meter strip dispenser assembly
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
CN100339044C (en) * 2001-03-29 2007-09-26 因弗内斯医疗有限公司 Integrated measuring apparatus for testing samples
US6549796B2 (en) * 2001-05-25 2003-04-15 Lifescan, Inc. Monitoring analyte concentration using minimally invasive devices
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
DE60234598D1 (en) 2001-06-12 2010-01-14 Pelikan Technologies Inc SELF-OPTIMIZING LANZET DEVICE WITH ADAPTANT FOR TEMPORAL FLUCTUATIONS OF SKIN PROPERTIES
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7682318B2 (en) 2001-06-12 2010-03-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
EP1404234B1 (en) 2001-06-12 2011-02-09 Pelikan Technologies Inc. Apparatus for improving success rate of blood yield from a fingerstick
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
US20080177154A1 (en) 2001-08-13 2008-07-24 Novo Nordisk A/S Portable Device and Method Of Communicating Medical Data Information
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
GB2388898B (en) * 2002-04-02 2005-10-05 Inverness Medical Ltd Integrated sample testing meter
US20040010233A1 (en) 2002-04-16 2004-01-15 Birger Hjertman System and a method for modification of a device and a device suitable for modification
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
EP1391794A1 (en) * 2002-07-23 2004-02-25 Novo Nordisk A/S Device with time indicating means
WO2004009160A1 (en) 2002-07-24 2004-01-29 M 2 Medical A/S An infusion pump system, an infusion pump unit and an infusion pump
WO2004041330A2 (en) 2002-11-05 2004-05-21 M 2 Medical A/S A disposable wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
US7175897B2 (en) * 2002-12-17 2007-02-13 Avery Dennison Corporation Adhesive articles which contain at least one hydrophilic or hydrophobic layer, method for making and uses for same
AU2003291963A1 (en) 2002-12-23 2004-07-14 M 2 Medical A/S Flexible piston rod
EP1583571B1 (en) 2002-12-23 2008-02-13 M2 Medical A/S Medical dispensing device for insulin
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
WO2004101432A2 (en) * 2003-05-12 2004-11-25 Johnsondiversey, Inc. Preparation of and dispensing chlorine dioxide
EP1628567B1 (en) 2003-05-30 2010-08-04 Pelikan Technologies Inc. Method and apparatus for fluid injection
DK1633235T3 (en) 2003-06-06 2014-08-18 Sanofi Aventis Deutschland Apparatus for sampling body fluid and detecting analyte
US7462265B2 (en) * 2003-06-06 2008-12-09 Lifescan, Inc. Reduced volume electrochemical sensor
US20040251132A1 (en) * 2003-06-06 2004-12-16 Leach Christopher Philip Reduced volume strip
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US8282549B2 (en) 2003-12-09 2012-10-09 Dexcom, Inc. Signal processing for continuous analyte sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US9135402B2 (en) * 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US7925321B2 (en) 2003-08-01 2011-04-12 Dexcom, Inc. System and methods for processing analyte sensor data
US8060173B2 (en) 2003-08-01 2011-11-15 Dexcom, Inc. System and methods for processing analyte sensor data
US8676287B2 (en) 2003-08-01 2014-03-18 Dexcom, Inc. System and methods for processing analyte sensor data
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8233959B2 (en) 2003-08-22 2012-07-31 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
WO2005051170A2 (en) 2003-11-19 2005-06-09 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
DE602004029092D1 (en) 2003-12-05 2010-10-21 Dexcom Inc CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTIC SENSOR
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US8147426B2 (en) * 2003-12-31 2012-04-03 Nipro Diagnostics, Inc. Integrated diagnostic test system
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2005072794A2 (en) * 2004-01-29 2005-08-11 M 2 Medical A/S Disposable medicine dispensing device
US8808228B2 (en) * 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
JP4549079B2 (en) * 2004-03-05 2010-09-22 パナソニック株式会社 Medical dosing device
ZA200501961B (en) * 2004-03-11 2005-09-19 Futumeds Sdn Bhd Lancet activating device.
US20050240119A1 (en) * 2004-04-16 2005-10-27 Becton, Dickinson And Company Blood glucose meter having integral lancet device and test strip storage vial for single handed use and methods for using same
EP2338511A3 (en) 2004-05-14 2012-07-25 Alexion Pharmaceuticals, Inc. Prolongation of survival of an allograft by inhibiting complement activity
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US7582262B2 (en) 2004-06-18 2009-09-01 Roche Diagnostics Operations, Inc. Dispenser for flattened articles
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US20060016700A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US7946984B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US7608042B2 (en) * 2004-09-29 2009-10-27 Intellidx, Inc. Blood monitoring system
WO2006037802A2 (en) 2004-10-07 2006-04-13 Novo Nordisk A/S Method and system for self- management of a disease
DE102004057503B4 (en) * 2004-11-29 2013-11-21 Roche Diagnostics Gmbh Diagnostic system for determining substance concentrations in liquid samples
EP1669020A1 (en) 2004-12-07 2006-06-14 Roche Diagnostics GmbH Storage case with integrated functions
US9259175B2 (en) * 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
KR20050030195A (en) * 2005-03-07 2005-03-29 최규동 Portable mechanical insulin injection device
WO2006107914A2 (en) * 2005-04-04 2006-10-12 Facet Technologies, Llc Narrow-profile lancing device
WO2006105792A1 (en) 2005-04-06 2006-10-12 M 2 Medical A/S Method and device for dispensing liquid medicine by means of a reversible electrical motor
US7534226B2 (en) 2005-09-26 2009-05-19 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US8105279B2 (en) 2005-09-26 2012-01-31 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US8057436B2 (en) 2005-09-26 2011-11-15 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
US8409142B2 (en) 2005-09-26 2013-04-02 Asante Solutions, Inc. Operating an infusion pump system
US7794427B2 (en) 2005-09-26 2010-09-14 Asante Solutions, Inc. Operating an infusion pump system
US8551046B2 (en) 2006-09-18 2013-10-08 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
US20090156964A1 (en) * 2005-09-27 2009-06-18 Creaven John P Flip-Top Integrated-Diagnostic Instrument
EP3064236B1 (en) 2005-11-08 2020-02-05 Bigfoot Biomedical, Inc. Method and system for manual and autonomous control of an infusion pump
ATE439155T1 (en) 2005-11-08 2009-08-15 M2 Medical As INFUSION PUMP SYSTEM
US20070123801A1 (en) * 2005-11-28 2007-05-31 Daniel Goldberger Wearable, programmable automated blood testing system
AU2007224250B2 (en) * 2006-03-02 2012-05-03 Alexion Pharmaceuticals, Inc. Prolongation of survival of an allograft by inhibiting complement activity
US7438694B2 (en) * 2006-03-07 2008-10-21 Agamatrix, Inc. Lancing device
CA2645065A1 (en) * 2006-04-24 2007-11-08 Richard Fuisz Bodily fluid analyzer, and system including same and method for programming same
US8092385B2 (en) 2006-05-23 2012-01-10 Intellidx, Inc. Fluid access interface
WO2007143225A2 (en) 2006-06-07 2007-12-13 Abbott Diabetes Care, Inc. Analyte monitoring system and method
ATE487417T1 (en) * 2006-07-14 2010-11-15 Hoffmann La Roche INJECTION DEVICE WITH A SECOND DEVICE FUNCTION FOR OBTAINING A BODY FLUID SAMPLE
US7981102B2 (en) 2007-05-21 2011-07-19 Asante Solutions, Inc. Removable controller for an infusion pump
US7833196B2 (en) 2007-05-21 2010-11-16 Asante Solutions, Inc. Illumination instrument for an infusion pump
US7892199B2 (en) 2007-05-21 2011-02-22 Asante Solutions, Inc. Occlusion sensing for an infusion pump
US7794426B2 (en) 2007-05-21 2010-09-14 Asante Solutions, Inc. Infusion pump system with contamination-resistant features
WO2008154312A1 (en) 2007-06-08 2008-12-18 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
DE602008006748D1 (en) 2007-08-29 2011-06-16 Brighter Ab PORTABLE MEDICAL DEVICE WITH SAMPLE DETERGENT, DETERGENT AND INJECTION AGENT
US7717903B2 (en) 2007-09-06 2010-05-18 M2 Group Holdings, Inc. Operating an infusion pump system
US7828528B2 (en) 2007-09-06 2010-11-09 Asante Solutions, Inc. Occlusion sensing system for infusion pumps
US8287514B2 (en) 2007-09-07 2012-10-16 Asante Solutions, Inc. Power management techniques for an infusion pump system
US7879026B2 (en) 2007-09-07 2011-02-01 Asante Solutions, Inc. Controlled adjustment of medicine dispensation from an infusion pump device
US7935076B2 (en) 2007-09-07 2011-05-03 Asante Solutions, Inc. Activity sensing techniques for an infusion pump system
US7935105B2 (en) 2007-09-07 2011-05-03 Asante Solutions, Inc. Data storage for an infusion pump system
US9452258B2 (en) 2007-10-09 2016-09-27 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
WO2009105709A1 (en) * 2008-02-21 2009-08-27 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
EP3260145B1 (en) * 2008-04-09 2019-12-11 Roche Diabetes Care GmbH Fluid level sensor for a modular skin-adherable system for medical fluid delivery
US8206353B2 (en) 2008-04-11 2012-06-26 Medtronic Minimed, Inc. Reservoir barrier layer systems and methods
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
KR20100032130A (en) * 2008-09-17 2010-03-25 주식회사 올메디쿠스 Dividable blood glucose test meter
EP2334234A4 (en) 2008-09-19 2013-03-20 Tandem Diabetes Care Inc Solute concentration measurement device and related methods
EP2349412B1 (en) 2008-10-01 2019-07-24 Novo Nordisk A/S Medical assembly with monitoring device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US20100256524A1 (en) 2009-03-02 2010-10-07 Seventh Sense Biosystems, Inc. Techniques and devices associated with blood sampling
US9446194B2 (en) 2009-03-27 2016-09-20 Dexcom, Inc. Methods and systems for promoting glucose management
US8753290B2 (en) 2009-03-27 2014-06-17 Intellectual Inspiration, Llc Fluid transfer system and method
WO2011014704A2 (en) 2009-07-30 2011-02-03 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
EP2482724A2 (en) 2009-09-30 2012-08-08 Dexcom, Inc. Transcutaneous analyte sensor
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
SI2563813T1 (en) 2010-04-30 2015-12-31 Alexion Pharmaceuticals, Inc. Anti-c5a antibodies and methods for using the antibodies
USD669165S1 (en) 2010-05-27 2012-10-16 Asante Solutions, Inc. Infusion pump
WO2011159930A2 (en) 2010-06-16 2011-12-22 Medtronic, Inc. Damping systems for stabilizing medications in drug delivery devices
MX2012014975A (en) 2010-06-22 2013-03-12 Univ Colorado Regents Antibodies to the c3d fragment of complement component 3.
US20130158482A1 (en) 2010-07-26 2013-06-20 Seventh Sense Biosystems, Inc. Rapid delivery and/or receiving of fluids
WO2012021801A2 (en) 2010-08-13 2012-02-16 Seventh Sense Biosystems, Inc. Systems and techniques for monitoring subjects
JP6150734B2 (en) 2011-02-03 2017-06-21 アレクシオン ファーマシューティカルズ, インコーポレイテッド Use of anti-CD200 antibodies to prolong allograft survival
US8647357B2 (en) 2011-02-05 2014-02-11 Birch Narrows Development Llc Lancet device with flexible cover
US8852152B2 (en) 2011-02-09 2014-10-07 Asante Solutions, Inc. Infusion pump systems and methods
US8454581B2 (en) 2011-03-16 2013-06-04 Asante Solutions, Inc. Infusion pump systems and methods
WO2012130992A1 (en) 2011-03-30 2012-10-04 Novo Nordisk A/S System for optimizing a patient's drug dosage regimen over time
DK3575796T3 (en) 2011-04-15 2021-01-18 Dexcom Inc ADVANCED ANALYZE SENSOR CALIBRATION AND ERROR DETECTION
EP2701598A1 (en) 2011-04-29 2014-03-05 Seventh Sense Biosystems, Inc. Systems and methods for collecting fluid from a subject
KR102237667B1 (en) 2011-04-29 2021-04-12 세븐쓰 센스 바이오시스템즈, 인크. Delivering and/or receiving fluids
EP2702406B1 (en) 2011-04-29 2017-06-21 Seventh Sense Biosystems, Inc. Plasma or serum production and removal of fluids under reduced pressure
US20130158468A1 (en) 2011-12-19 2013-06-20 Seventh Sense Biosystems, Inc. Delivering and/or receiving material with respect to a subject surface
US8585657B2 (en) 2011-06-21 2013-11-19 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
JP6285363B2 (en) * 2011-11-23 2018-02-28 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Method and medical device for adjusting the dose of a fluid medicament
US9572922B2 (en) 2012-12-21 2017-02-21 Larry Leonard Inventive diabetic systems, tools, kits, and supplies for better diabetic living and mobility
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8454562B1 (en) 2012-07-20 2013-06-04 Asante Solutions, Inc. Infusion pump system and method
PT106756A (en) * 2013-01-28 2014-07-28 Carlos Manuel Dos Santos Videira AUTOMATED MOBILE DEVICE FOR DIABETICS, CONSTITUTED FOR THE INTEGRATION OF A DIGITAL GLUE METER FOR THE DETERMINATION OF CAPILLARY GLYCEMIA AND A PEN THAT IS AUTO DOSED WITH A STEAM ENGINE RESOURCE FOR INSULIN ADMINISTRATION
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
EP2978451B1 (en) 2013-03-29 2019-11-27 Alexion Pharmaceuticals, Inc. Compositions and methods for increasing the serum half-life of a therapeutic agent targeting complement c5
US9237866B2 (en) * 2013-04-29 2016-01-19 Birch Narrows Development, LLC Blood glucose management
US9457141B2 (en) 2013-06-03 2016-10-04 Bigfoot Biomedical, Inc. Infusion pump system and method
CA2910596C (en) 2013-07-19 2021-07-20 Dexcom, Inc. Time averaged basal rate optimizer
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
CA2925458C (en) 2013-09-26 2021-11-30 Companion Medical, Inc. System for administering a medicament
CN104634611B (en) * 2013-11-14 2018-07-13 艾博生物医药(杭州)有限公司 A method of the device of quantitative shunting is carried out to liquid sample and uses the device
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
CN104857601A (en) * 2014-02-26 2015-08-26 王峻 Automatic acupuncture-type insulin injection pen
NZ631007A (en) 2014-03-07 2015-10-30 Alexion Pharma Inc Anti-c5 antibodies having improved pharmacokinetics
US9629901B2 (en) * 2014-07-01 2017-04-25 Bigfoot Biomedical, Inc. Glucagon administration system and methods
EP3659651A3 (en) 2014-07-10 2020-10-14 Companion Medical, Inc. Medicine administering system including injection pen and companion device
US10137246B2 (en) 2014-08-06 2018-11-27 Bigfoot Biomedical, Inc. Infusion pump assembly and method
US9919096B2 (en) 2014-08-26 2018-03-20 Bigfoot Biomedical, Inc. Infusion pump system and method
US10704944B2 (en) 2014-09-14 2020-07-07 Becton, Dickinson And Company System and method for capturing dose information
US10971260B2 (en) 2014-09-14 2021-04-06 Becton, Dickinson And Company System and method for capturing dose information
KR20160075907A (en) * 2014-12-19 2016-06-30 한국생산기술연구원 Drug Infusion Device Having Sliding Mount Unit
WO2016123282A1 (en) * 2015-01-28 2016-08-04 Seventh Sense Biosystems, Inc. Devices and methods for delivering and/or receiving fluid
EP3274017B1 (en) * 2015-03-23 2020-08-26 Adan Medical Innovation S.L. Controlling products contained in container devices
US9878097B2 (en) 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system
US10745481B2 (en) 2015-05-04 2020-08-18 Cytomx Therapeutics, Inc. Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
CN105528748A (en) * 2015-06-16 2016-04-27 江苏德尔福医疗器械有限公司 Blood sugar real-time monitoring, management and treatment system
EP4310503A3 (en) 2015-12-30 2024-03-20 Momenta Pharmaceuticals, Inc. Methods related to biologics
US10449294B1 (en) 2016-01-05 2019-10-22 Bigfoot Biomedical, Inc. Operating an infusion pump system
EP3374900A1 (en) 2016-01-05 2018-09-19 Bigfoot Biomedical, Inc. Operating multi-modal medicine delivery systems
EP3407940A4 (en) 2016-01-29 2019-09-04 Companion Medical, Inc. Automatic medication delivery tracking
USD809134S1 (en) 2016-03-10 2018-01-30 Bigfoot Biomedical, Inc. Infusion pump assembly
USD831194S1 (en) * 2016-04-29 2018-10-16 Csl Behring Recombinant Facility Ag Syringe pump housing
USD831821S1 (en) * 2016-04-29 2018-10-23 Csl Behring Recombinant Facility Ag Syringe pump housing
USD831820S1 (en) * 2016-04-29 2018-10-23 Csl Behring Recombinant Facility Ag Syringe pump housing
USD829434S1 (en) * 2016-04-29 2018-10-02 Csl Behring Recombinant Facility Ag Syringe pump housing
USD811722S1 (en) * 2016-08-17 2018-03-06 Stephen Padden Collapsible container
WO2018064219A1 (en) 2016-09-27 2018-04-05 Bigfoot Biomedical, Inc. Personalizing preset meal sizes in insulin delivery system
AU2017376111B2 (en) 2016-12-12 2023-02-02 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
USD836769S1 (en) 2016-12-12 2018-12-25 Bigfoot Biomedical, Inc. Insulin delivery controller
CN110234380A (en) * 2016-12-13 2019-09-13 伯克顿迪金森公司 Event capture equipment for drug delivery machinery
EP3398630A1 (en) * 2017-05-03 2018-11-07 Sanofi-Aventis Deutschland GmbH Auto-injector storage device
WO2018227163A1 (en) 2017-06-09 2018-12-13 Companion Medical, Inc. Intelligent medication delivery systems and methods
USD839294S1 (en) 2017-06-16 2019-01-29 Bigfoot Biomedical, Inc. Display screen with graphical user interface for closed-loop medication delivery
WO2019014594A1 (en) 2017-07-13 2019-01-17 Desborough Lane Multi-scale display of blood glucose information
AU2018300237A1 (en) 2017-07-14 2020-01-16 Cytomx Therapeutics, Inc. Anti-CD166 antibodies and uses thereof
WO2019023564A1 (en) 2017-07-27 2019-01-31 Alexion Pharmaceutical, Inc. High concentration anti-c5 antibody formulations
USD860636S1 (en) * 2017-09-13 2019-09-24 Mimi Medcessories LLC Seven day pillbox
US11568975B2 (en) 2017-10-12 2023-01-31 Medtronic Minimed, Inc. Intelligent medication delivery systems and methods for dose recommendation and management
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US20190120785A1 (en) 2017-10-24 2019-04-25 Dexcom, Inc. Pre-connected analyte sensors
US11116899B2 (en) 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
US11077243B2 (en) 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
US11464459B2 (en) * 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
US11197964B2 (en) 2017-12-12 2021-12-14 Bigfoot Biomedical, Inc. Pen cap for medication injection pen having temperature sensor
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11083852B2 (en) 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
US11027073B2 (en) 2017-12-12 2021-06-08 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
US20210087267A1 (en) 2017-12-20 2021-03-25 Alexion Pharmaceuticals, Inc. Liquid formulations of anti-cd200 antibodies
USD861170S1 (en) * 2018-02-19 2019-09-24 Socrates Health Solutions, Inc. Pen device
US11664107B2 (en) 2018-05-08 2023-05-30 Medtronic Minimed, Inc. Intelligent medication delivery systems and methods using a prescription-regulated software application
US10898653B2 (en) 2018-05-08 2021-01-26 Companion Medical, Inc. Intelligent medication delivery systems and methods for dose setting and dispensing monitoring
USD893020S1 (en) 2018-05-11 2020-08-11 Companion Medical, Inc. Injection pen
US11587663B2 (en) 2018-06-20 2023-02-21 Medtronic Minimed, Inc. Intelligent medication delivery systems and methods for medicine dose calculation and reporting
USD892819S1 (en) 2018-06-20 2020-08-11 Companion Medical, Inc. Display screen with graphical user interface
BR112021012172A2 (en) 2018-12-12 2021-08-31 Kite Pharma, Inc. CHIMERIC AND T-CELL ANTIGEN RECEPTORS AND METHODS OF USE
US11948671B2 (en) 2019-04-11 2024-04-02 Medtronic Minimed, Inc. Intelligent accessories for medicine dispensing device
CA3138188A1 (en) 2019-07-02 2021-01-07 Fred Hutchinson Cancer Research Center Recombinant ad35 vectors and related gene therapy improvements
CA3176425A1 (en) 2020-04-24 2021-10-28 Millennium Pharmaceuticals, Inc. Anti-cd19 antibodies and uses thereof
US11951284B2 (en) 2020-08-27 2024-04-09 Tandem Diabetes Care, Inc. Transitioning to other modes in automated insulin delivery
EP4211164A1 (en) 2020-09-14 2023-07-19 Vor Biopharma Inc. Single domain antibodies against cd33
WO2022064966A1 (en) * 2020-09-23 2022-03-31 テルモ株式会社 Component measurement apparatus
IL303741A (en) 2020-12-18 2023-08-01 Momenta Pharmaceuticals Inc Antibodies against integrin alpha 11 beta 1
JP2024515066A (en) 2021-04-09 2024-04-04 武田薬品工業株式会社 Antibodies targeting complement factor D and uses thereof
EP4330283A1 (en) 2021-04-26 2024-03-06 Millennium Pharmaceuticals, Inc. Anti-adgre2 antibodies and uses thereof
AR125451A1 (en) 2021-04-26 2023-07-19 Millennium Pharm Inc ANTI-CLEC12A ANTIBODIES AND USES THEREOF
US11701473B2 (en) 2021-06-23 2023-07-18 Medtronic Minimed, Inc. Reusable injection pens
WO2023068382A2 (en) 2021-10-20 2023-04-27 Takeda Pharmaceutical Company Limited Compositions targeting bcma and methods of use thereof
WO2023201238A1 (en) 2022-04-11 2023-10-19 Vor Biopharma Inc. Binding agents and methods of use thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469110A (en) * 1981-06-25 1984-09-04 Slama Gerard J Device for causing a pinprick to obtain and to test a drop of blood
US4995402A (en) * 1988-10-12 1991-02-26 Thorne, Smith, Astill Technologies, Inc. Medical droplet whole blood and like monitoring
US5489414A (en) * 1993-04-23 1996-02-06 Boehringer Mannheim, Gmbh System for analyzing compounds contained in liquid samples
US5536249A (en) * 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
US5665065A (en) * 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009579A1 (en) * 1993-10-07 1995-04-13 Muodonmuutos Oy Patient's container of medical equipment for use at home

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469110A (en) * 1981-06-25 1984-09-04 Slama Gerard J Device for causing a pinprick to obtain and to test a drop of blood
US4995402A (en) * 1988-10-12 1991-02-26 Thorne, Smith, Astill Technologies, Inc. Medical droplet whole blood and like monitoring
US5489414A (en) * 1993-04-23 1996-02-06 Boehringer Mannheim, Gmbh System for analyzing compounds contained in liquid samples
US5536249A (en) * 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
US5728074A (en) * 1994-03-09 1998-03-17 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
US5665065A (en) * 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input

Cited By (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6808514B2 (en) * 2000-10-17 2004-10-26 Patricia G. Schneider Emergency medical dispensing card
US20020074345A1 (en) * 2000-10-17 2002-06-20 Schneider Patricia G. Emergency medical dispensing card
US20040054318A1 (en) * 2000-12-22 2004-03-18 Langley Christopher Nigel Pen-type injector having an electronic control unit
US8926553B2 (en) 2000-12-22 2015-01-06 Christopher Nigel Langley Pen-type injector having an electronic control unit
US20050126938A1 (en) * 2002-02-15 2005-06-16 Yoshiharu Uehata Integrally storable adaptor
US7562774B2 (en) * 2002-02-15 2009-07-21 Arkray, Inc. Kit holding adapter
US10039881B2 (en) 2002-12-31 2018-08-07 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US10750952B2 (en) 2002-12-31 2020-08-25 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8682598B2 (en) 2003-04-04 2014-03-25 Abbott Laboratories Method and system for transferring analyte test data
US8560250B2 (en) 2003-04-04 2013-10-15 Abbott Laboratories Method and system for transferring analyte test data
US8437966B2 (en) 2003-04-04 2013-05-07 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US20100309001A1 (en) * 2003-04-04 2010-12-09 Abbott Diabetes Care Inc. Method and System for Transferring Analyte Test Data
US8483974B2 (en) 2003-04-04 2013-07-09 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US20100121168A1 (en) * 2003-04-04 2010-05-13 Abbott Diabetes Care Inc. Method and System for Transferring Analyte Test Data
US20100076288A1 (en) * 2003-04-04 2010-03-25 Brian Edmond Connolly Method and System for Transferring Analyte Test Data
US20090284372A1 (en) * 2003-06-10 2009-11-19 Abbott Diabetes Care Inc. Glucose Measuring Device For Use In Personal Area Network
US8512239B2 (en) * 2003-06-10 2013-08-20 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US9730584B2 (en) 2003-06-10 2017-08-15 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US20050182306A1 (en) * 2004-02-17 2005-08-18 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US7901383B2 (en) 2004-04-30 2011-03-08 Becton, Dickinson And Company Systems and methods for administering a medical regimen
US20090200185A1 (en) * 2004-04-30 2009-08-13 Becton, Dickinson And Company Systems and methods for administering a medical regimen
US7534230B2 (en) 2004-04-30 2009-05-19 Becton, Dickinson And Company Systems and methods for administering a medical regimen
US20070239116A1 (en) * 2004-04-30 2007-10-11 Mark Follman Systems and methods for administering a medical regimen
US20060034728A1 (en) * 2004-08-11 2006-02-16 Kloepfer Hans G Methods and apparatus for analyzing an analysis fluid
EP1625823A3 (en) * 2004-08-11 2006-05-03 Micronix, Inc. Methods and apparatus for analysing a fluid
US7695676B2 (en) 2004-08-11 2010-04-13 Hans Kloepfer Methods and apparatus for analyzing an analysis fluid
US20060047284A1 (en) * 2004-08-25 2006-03-02 Gresham Richard D Gel seal for a surgical trocar apparatus
US8241251B2 (en) 2004-08-25 2012-08-14 Tyco Healthcare Group Lp Gel seal for a surgical trocar apparatus
US8708963B2 (en) 2004-08-25 2014-04-29 Covidien Lp Gel seal for a surgical trocar apparatus
US20090054747A1 (en) * 2005-10-31 2009-02-26 Abbott Diabetes Care, Inc. Method and system for providing analyte sensor tester isolation
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US11538580B2 (en) 2005-11-04 2022-12-27 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8585591B2 (en) 2005-11-04 2013-11-19 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US20100274220A1 (en) * 2005-11-04 2010-10-28 Abbott Diabetes Care Inc. Method and System for Providing Basal Profile Modification in Analyte Monitoring and Management Systems
US9669162B2 (en) 2005-11-04 2017-06-06 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US20100045231A1 (en) * 2006-03-31 2010-02-25 Abbott Diabetes Care Inc. Method and System for Powering an Electronic Device
US8933664B2 (en) 2006-03-31 2015-01-13 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9039975B2 (en) 2006-03-31 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9380971B2 (en) 2006-03-31 2016-07-05 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9625413B2 (en) 2006-03-31 2017-04-18 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9743863B2 (en) 2006-03-31 2017-08-29 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US20090105571A1 (en) * 2006-06-30 2009-04-23 Abbott Diabetes Care, Inc. Method and System for Providing Data Communication in Data Management Systems
US10617823B2 (en) 2007-02-15 2020-04-14 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US10022499B2 (en) 2007-02-15 2018-07-17 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9801545B2 (en) 2007-03-01 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8593287B2 (en) 2007-05-08 2013-11-26 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20090318792A1 (en) * 2007-05-08 2009-12-24 Fennell Martin J Analyte Monitoring System and Methods
US10952611B2 (en) 2007-05-08 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9649057B2 (en) 2007-05-08 2017-05-16 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9314198B2 (en) 2007-05-08 2016-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US11696684B2 (en) 2007-05-08 2023-07-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9949678B2 (en) 2007-05-08 2018-04-24 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US20080278332A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281179A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US10178954B2 (en) 2007-05-08 2019-01-15 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10653317B2 (en) 2007-05-08 2020-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20080281171A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US20080278333A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281840A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8617069B2 (en) 2007-06-21 2013-12-31 Abbott Diabetes Care Inc. Health monitor
US20100076284A1 (en) * 2007-06-21 2010-03-25 Abbott Diabetes Care Inc. Health Management Devices and Methods
US20100076291A1 (en) * 2007-06-21 2010-03-25 Abbott Diabetes Care Inc. Health Monitor
US20080319296A1 (en) * 2007-06-21 2008-12-25 Abbott Diabetes Care, Inc. Health monitor
US20100076280A1 (en) * 2007-06-21 2010-03-25 Abbott Diabetes Care Inc. Health Monitor
US20100076289A1 (en) * 2007-06-21 2010-03-25 Abbott Diabetes Care Inc. Health Monitor
US20100076290A1 (en) * 2007-06-21 2010-03-25 Abbott Diabetes Care Inc. Health Monitor
US11276492B2 (en) 2007-06-21 2022-03-15 Abbott Diabetes Care Inc. Health management devices and methods
US20100076292A1 (en) * 2007-06-21 2010-03-25 Abbott Diabetes Care Inc. Health Monitor
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
US11264133B2 (en) 2007-06-21 2022-03-01 Abbott Diabetes Care Inc. Health management devices and methods
US20090043265A1 (en) * 2007-08-10 2009-02-12 Schneider Robert M Method and apparatus for auto injection of a therapeutic
US20090076465A1 (en) * 2007-09-17 2009-03-19 Tyco Healthcare Group Lp Composite seal and method for manufacturing
US20110044333A1 (en) * 2008-05-30 2011-02-24 Abbott Diabetes Care Inc. Close Proximity Communication Device and Methods
US9184875B2 (en) 2008-05-30 2015-11-10 Abbott Diabetes Care, Inc. Close proximity communication device and methods
US11770210B2 (en) 2008-05-30 2023-09-26 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8737259B2 (en) 2008-05-30 2014-05-27 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8509107B2 (en) 2008-05-30 2013-08-13 Abbott Diabetes Care Inc. Close proximity communication device and methods
US9831985B2 (en) 2008-05-30 2017-11-28 Abbott Diabetes Care Inc. Close proximity communication device and methods
US11202591B2 (en) 2009-02-03 2021-12-21 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006870B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11213229B2 (en) 2009-02-03 2022-01-04 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US20100198034A1 (en) * 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
US11166656B2 (en) 2009-02-03 2021-11-09 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006871B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006872B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9088452B2 (en) 2009-04-29 2015-07-21 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US10172518B2 (en) 2009-04-29 2019-01-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9693688B2 (en) 2009-04-29 2017-07-04 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9949639B2 (en) 2009-04-29 2018-04-24 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US10617296B2 (en) 2009-04-29 2020-04-14 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US11872370B2 (en) 2009-05-29 2024-01-16 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
USD1010133S1 (en) 2009-08-31 2024-01-02 Abbott Diabetes Care Inc. Analyte sensor assembly
US10136816B2 (en) 2009-08-31 2018-11-27 Abbott Diabetes Care Inc. Medical devices and methods
US20110054282A1 (en) * 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte Monitoring System and Methods for Managing Power and Noise
US10429250B2 (en) 2009-08-31 2019-10-01 Abbott Diabetes Care, Inc. Analyte monitoring system and methods for managing power and noise
US10492685B2 (en) 2009-08-31 2019-12-03 Abbott Diabetes Care Inc. Medical devices and methods
US20110060530A1 (en) * 2009-08-31 2011-03-10 Abbott Diabetes Care Inc. Analyte Signal Processing Device and Methods
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9968302B2 (en) 2009-08-31 2018-05-15 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US11635332B2 (en) 2009-08-31 2023-04-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US20110213225A1 (en) * 2009-08-31 2011-09-01 Abbott Diabetes Care Inc. Medical devices and methods
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US11150145B2 (en) 2009-08-31 2021-10-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US11045147B2 (en) 2009-08-31 2021-06-29 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9358334B2 (en) 2010-08-18 2016-06-07 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US8206340B2 (en) * 2010-08-18 2012-06-26 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US20120046606A1 (en) * 2010-08-18 2012-02-23 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9465420B2 (en) 2011-10-31 2016-10-11 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US11950936B2 (en) 2012-09-17 2024-04-09 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US11612363B2 (en) 2012-09-17 2023-03-28 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US10318915B2 (en) 2012-09-26 2019-06-11 Thuban, Inc. Healthcare system for recording and monitoring transactions of system participants
US9357961B2 (en) 2013-02-22 2016-06-07 Thuban, Inc. Device for enabling patient self testing and treatment self- administration and system using the device for managing the patient's health care
US9861768B2 (en) 2014-01-28 2018-01-09 Panasonic Healthcare Holdings Co., Ltd. Pharmaceutical injection device, and pharmaceutical management system
US20170232184A1 (en) * 2014-08-05 2017-08-17 Hunter S. BIHN Diabetic Medication Delivery Pen Packet
WO2016022704A1 (en) * 2014-08-05 2016-02-11 Bihn Hunter S Diabetic medication delivery pen packet
US10850023B2 (en) * 2014-08-05 2020-12-01 Hunter S. BIHN Diabetic medication delivery pen packet
US10857304B2 (en) 2016-03-25 2020-12-08 Eli Lilly And Company Determination of a dose set and delivered in a medication delivery device
US11266788B2 (en) 2016-04-19 2022-03-08 Eli Lilly And Company Determination of a dose in a medication delivery device using two moving arrays with teeth and a sensor
US11471607B2 (en) 2016-08-12 2022-10-18 Eli Lilly And Company Dose sensing mechanism in a medication delivery device
US20180058521A1 (en) * 2016-08-31 2018-03-01 Otis Elevator Company Auxiliary brake device, brake disc assembly, base disc assembly and passenger conveyor
US11452819B2 (en) 2016-12-15 2022-09-27 Eli Lilly And Company Medication delivery device with sensing system
US11497855B2 (en) * 2019-10-18 2022-11-15 Ainos, Inc. Smart drug injection device
US20210113777A1 (en) * 2019-10-18 2021-04-22 Amarillo Biosciences, Inc Smart drug injection device

Also Published As

Publication number Publication date
CZ20004261A3 (en) 2001-06-13
AU3810499A (en) 1999-12-06
CA2332368C (en) 2007-05-15
DE69911767D1 (en) 2003-11-06
HUP0102074A2 (en) 2001-10-28
NO20005815L (en) 2001-01-16
WO1999059657A1 (en) 1999-11-25
HUP0102074A3 (en) 2001-12-28
TW477685B (en) 2002-03-01
CA2332368A1 (en) 1999-11-25
US20070244412A1 (en) 2007-10-18
AU748281B2 (en) 2002-05-30
US6302855B1 (en) 2001-10-16
KR20010025042A (en) 2001-03-26
BR9911051A (en) 2001-02-06
JP2002515302A (en) 2002-05-28
DE69911767T2 (en) 2004-08-12
EP1079876A1 (en) 2001-03-07
RU2221594C2 (en) 2004-01-20
CN1301184A (en) 2001-06-27
ES2207942T3 (en) 2004-06-01
EP1079876B1 (en) 2003-10-01
ZA200006159B (en) 2001-06-25
IL139242A0 (en) 2001-11-25
NO20005815D0 (en) 2000-11-17
PT1079876E (en) 2004-02-27
ATE250945T1 (en) 2003-10-15
PL344305A1 (en) 2001-10-22
DK1079876T3 (en) 2004-01-26

Similar Documents

Publication Publication Date Title
EP1079876B1 (en) A medical apparatus for use by a patient for medical self treatment of diabetes
AU2002354523B2 (en) Method and system for controlling data information between two portable medical apparatuses
EP0749332B1 (en) Medication delivery device with a microprocessor and characteristic monitor
US8551039B2 (en) Drug delivery with event notification
CA2303010C (en) Integrated system including medication delivery pen, blood monitoring device, and lancer
US20030032868A1 (en) Method and system for controlling data information between two portable apparatuses
US20040039255A1 (en) Medical system and a method of controlling the system for use by a patient for medical self treatment
US20070293742A1 (en) Medical System And A Method Of Controlling The System For Use By A Patient For Medical Self Treatment
AU2002354523A1 (en) Method and system for controlling data information between two portable medical apparatuses
US20130338464A1 (en) Self-contained blood glucose testing apparatus
EP1669020A1 (en) Storage case with integrated functions
MXPA00011344A (en) A medical apparatus for use by a patient for medical self treatment of diabetes

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION